Versatile methodology for the synthesis and α-functionalization of (2R,3aS,7aS)-octahydroindole-2-carboxylic acid

Tetrahedron

Volumn 64, Issue 1, 2008, Pages 84-91

  Sayago, Francisco J ^a   Isabel Calaza, M ^a   Jiménez, Ana I ^a   Cativiela, Carlos ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Alkylation; Bicyclic proline analogue; Crystal structure; Perhydroindole 2 carboxylic acid; Quaternary amino acid; Self reproduction of chirality; Trichloromethyloxazolidinone

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; OCTAHYDROINDOLE 2 CARBOXYLIC ACID; OXAZOLIDINONE DERIVATIVE; PROLINE DERIVATIVE; TRICHLOROMETHYLOXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANALYTIC METHOD; ARTICLE; CHIRALITY; CRYSTAL STRUCTURE; PRIORITY JOURNAL; REACTION ANALYSIS; STEREOCHEMISTRY; STEREOISOMERISM; SYNTHESIS;

EID: 36348968945     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.10.095     Document Type: Article

References (38)

1. Adessi C., and Soto C. Curr. Med. Chem. 9 (2002) 963-978
2. Cowell S.M., Lee Y.S., Cain J.P., and Hruby V.J. Curr. Med. Chem. 11 (2004) 2785-2798
3. Toniolo C., Crisma M., Formaggio F., and Peggion C. Biopolymers (Pept. Sci.) 60 (2001) 396-419
4. Hruby V.J., Li G., Haskell-Luevano C., and Shenderovich M. Biopolymers (Pept. Sci.) 43 (1997) 219-266
5. Karoyan P., Sagan S., Lequin O., Quancard J., Lavielle S., and Chassaing G. Substituted Prolines: Syntheses and Applications in Structure-Activity Relationship Studies of Biologically Active Peptides. In: Attanasi O.A., and Spinelli D. (Eds). Targets in Heterocyclic Systems: Chemistry and Properties Vol. 8 (2005), Royal Society of Chemistry, Cambridge 216-273
6. van de Waterbeemd H., Karajiannis H., and El Tayar N. Amino Acids 7 (1994) 129-145
7. El Tayar N., Karajiannis H., and van de Waterbeemd H. Amino Acids 8 (1995) 125-139
8. Reissmann S., and Imhof D. Curr. Med. Chem. 11 (2004) 2823-2844
9. Stewart J.M. Peptides 25 (2004) 527-532
10. Monteagudo E.S., Calvani F., Catrambone F., Fincham C.I., Madami A., Meini S., and Terracciano R. J. Pept. Sci. 7 (2001) 270-283
11. Alfakih K., and Hall A.S. Expert Opin. Pharmacother. 7 (2006) 63-71
12. Hurst M., and Jarvis B. Drugs 61 (2001) 867-896
13. Todd P.A., and Fitton A. Drugs 42 (1991) 90-114
14. Hanessian S., Del Valle J.R., Xue Y., and Blomberg N. J. Am. Chem. Soc. 128 (2006) 10491-10495
15. Hanessian S., Tremblay M., and Petersen J.F.W. J. Am. Chem. Soc. 126 (2004) 6064-6071
16. Carroll A.R., Pierens G.K., Fechner G., de Almeida Leone P., Ngo A., Simpson M., Hyde E., Hooper J.N.A., Boström S.-L., Musil D., and Quinn R.J. J. Am. Chem. Soc. 124 (2002) 13340-13341
17. Barvian, N. C.; Connolly, C. J. C.; Guzzo, P. R.; Hamby, J. M.; Hicks, J. L.; Johnson, M. R.; Le, V.-D.; Mitchell, L. H.; Roark, W. H. PCT Patent WO 2004092132, 2004.
18. Belvisi L., Colombo L., Colombo M., Di Giacomo M., Manzoni L., Vodopivec B., and Scolastico C. Tetrahedron 57 (2001) 6463-6473
19. Pyne S.G., Javidan A., Skelton B.W., and White A.H. Tetrahedron 51 (1995) 5157-5168
20. Vincent M., Marchand B., Remond G., Jaguelin-Guinamant S., Damien G., Portevin B., Baumal J.-Y., Volland J.-P., Bouchet J.-P., Lambert P.-H., Serkiz B., Luitjen W., Laubie M., and Schiavi P. Drug Des. Discov. 9 (1992) 11-28
21. Blankley C.J., Kaltenbronn J.S., DeJohn D.E., Werner A., Bennett L.R., Bobowski G., Krolls U., Johnson D.R., Pearlman W.M., Hoefle M.L., Essenburg A.D., Cohen D.M., and Kaplan H.R. J. Med. Chem. 30 (1987) 992-998
22. Vincent M., Remond G., Portevin B., Serkiz B., and Laubie M. Tetrahedron Lett. 23 (1982) 1677-1680
23. Hirata, N. U.S. Patent 0,106,690, 2005.
24. Sayago F.J., Jiménez A.I., and Cativiela C. Tetrahedron: Asymmetry 18 (2007) 2358-2364
25. Yamada S., Hongo C., Yoshioka R., and Chibata I. J. Org. Chem. 48 (1983) 843-846
26. Henning R., and Urbach H. Tetrahedron Lett. 24 (1983) 5339-5342
27. Seebach D., Boes M., Naef R., and Schweizer W.B. J. Am. Chem. Soc. 105 (1983) 5390-5398
28. Orsini F., Pelizzoni F., Forte M., Sisti M., Bombieri G., and Benetollo F. J. Heterocycl. Chem. 26 (1989) 837-841
29. Germanas J.P., and Wang H. Synlett (1999) 33-36
30. Note that the order of stereochemical descriptors R/S obey different numeration profiles in compounds 1 and 2. In particular, the α carbon occupies position 2 in the former and position 9a in the latter. Abbreviated names, with and without numerical locants, are exemplified below for clarity. {A figure is presented}
31. Amedjkouh M., and Ahlberg P. Tetrahedron: Asymmetry 13 (2002) 2229-2234
32. The preparation of trichloromethyloxazolidinones was preferred to tert-butyloxazolidinones because of their greater stability. In the case of proline, the corresponding trichloromethyloxazolidinone is a crystalline solid, while the tert-butyl derivative is highly sensitive to hydrolysis and unstable in air.
33. Unreacted (S,S,S)-1 can be isolated, if desired, by washing the silica pad with MeOH.
34. DeTar D.F., and Luthra N.P. J. Am. Chem. Soc. 99 (1977) 1232-1244
35. Ashida T., and Kakudo M. Bull. Chem. Soc. Jpn. 47 (1974) 1129-1133
36. Although the relative spatial disposition of substituents at carbon 9a is identical for all three tetrasubstituted compounds 3a-c, the stereochemical descriptors R/S giving the absolute configuration of the carbon centre differ. Thus, the compound with a benzyl substituent (3b) has an S configuration at position 9a due to the different priority of the substituents in comparison with the methyl or allyl derivatives.
37. Sheldrick G.M. SHELXS-97, Program for the Solution of Crystal Structures (1997), University of Göttingen, Göttingen
38. Sheldrick G.M. SHELXL-97, Program for the Refinement of Crystal Structures (1997), University of Göttingen, Göttingen